Mediviscum

Mediviscum was a specialized German pharmaceutical company focused on the development and manufacture of mistletoe (Viscum album) extracts for use in complementary oncology. Established in 1973 and headquartered in Pforzheim, the firm produced standardized injectable preparations designed to support the immune systems of patients undergoing cancer treatment. These anthroposophic medicines were primarily used to enhance the quality of life and mitigate the immunosuppressive effects of chemotherapy and radiation. The company's core product line, marketed under the Mediviscum name, became a recognized brand in the field of integrative medicine in Europe. Mediviscum was subsequently acquired by Madaus AG, leading to the integration of its mistletoe research and production into Madaus's extensive phytopharmaceutical operations.